Last reviewed · How we verify
Cutivate (FLUTICASONE PROPIONATE)
Cutivate (generic name: FLUTICASONE PROPIONATE) is a Corticosteroid Small molecule drug developed by Teva Pharm. It is currently FDA-approved (first approved 1990) for Allergic asthma, Allergic rhinitis, Asthma management.
Cutivate, also known as fluticasone, is a small molecule medication used to treat various conditions, including Coronavirus Infection (COVID-19), Pulmonary Arterial Hypertension, and Pain, among others. It is administered via inhalation and is prescribed per standard of care, with its pharmacokinetics, pharmacodynamics, and safety profile being studied in children.
At a glance
| Generic name | FLUTICASONE PROPIONATE |
|---|---|
| Sponsor | Teva Pharm |
| Drug class | Corticosteroid |
| Target | Glucocorticoid receptor |
| Modality | Small molecule |
| Therapeutic area | Oncology |
| Phase | FDA-approved |
| First approval | 1990 |
| Annual revenue | 69 |
Approved indications
- Allergic asthma
- Allergic rhinitis
- Asthma management
- Atopic dermatitis
- Bronchospasm Prevention with COPD
- COPD Associated with Chronic Bronchitis
- Chronic Non-Allergic Rhinitis
- Contact dermatitis
- Discoid lupus erythematosus
- Eruption of skin
- Granuloma annulare
- Lichen simplex chronicus
- Non-allergic asthma
- Plaque psoriasis
- Primary cutaneous T-cell lymphoma
- Pruritus ani
- Pruritus of genital organs
- Pulmonary emphysema
- Scalp psoriasis
- Seborrheic dermatitis
Common side effects
- Ear, nose, and throat disorders
- Tremor
- Headache
- Palpitations
- Neurology disorders
- Muscle injuries
- Lower respiratory disorders
- Viral infections
- Musculoskeletal disorders
- Gastrointestinal signs and symptoms
- Nasal sinus disorders
- Sleep disorders
Serious adverse events
- Pneumonia
- Elevation of hepatic enzymes
- Fractures
- Keratitis and conjunctivitis
Key clinical trials
- A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma Exacerbations (PHASE3)
- Pragmatic Open - Label Randomized Clinical Trial of FF/UMEC/VI vs Non-ellipta Usual Care ICS-LABA for Adult Participants With Uncontrolled Asthma (PHASE4)
- Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma (PHASE2)
- Efficacy and Safety of 186 mcg of OPN-375 Nasal Spray Twice a Day (BID) in Adolescents With Chronic Rhinosinusitis Without Nasal Polyps (PHASE3)
- A Trial to Evaluate EP-104GI in Adults With Eosinophilic Esophagitis (EoE). (PHASE1,PHASE2)
- A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma (PHASE3)
- Efficacy of Low-Dose Topical Steroids in Maintaining Remission of Eosinophilic Esophagitis in Children
- Effect of Novel Exhalational Delivery System With Fluticasone (EDS-FLU) on Eustachian Tube Dysfunction (ETD) (PHASE2)
Patents
| Patent | Expiry | Type |
|---|---|---|
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| FDA label | Mechanism, indications, dosing, boxed warnings, drug interactions |
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
| FDA Orange Book | Patents + exclusivity |
| SEC EDGAR | Revenue + earnings |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Cutivate CI brief — competitive landscape report
- Cutivate updates RSS · CI watch RSS
- Teva Pharm portfolio CI
Frequently asked questions about Cutivate
What is Cutivate?
What is Cutivate used for?
Who makes Cutivate?
What is the generic name of Cutivate?
What drug class is Cutivate in?
When was Cutivate approved?
What development phase is Cutivate in?
What are the side effects of Cutivate?
What is Cutivate's annual revenue?
What does Cutivate target?
Related
- Drug class: All Corticosteroid drugs
- Target: All drugs targeting Glucocorticoid receptor
- Manufacturer: Teva Pharm — full pipeline
- Therapeutic area: All drugs in Oncology
- Indication: Drugs for Allergic asthma
- Indication: Drugs for Allergic rhinitis
- Indication: Drugs for Asthma management
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing